[1]
“Monoclonal antibody therapy for refractory chronic migraine-like headache related Lyme disease: a case report”, Headache Med, vol. 15, no. 2, pp. 107–110, Jun. 2024, doi: 10.48208/HeadacheMed.2024.22.